First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study
Andreasen, Niels, Simeoni, Monica, Ostlund, Henrik, Lisjo, Pia I, Fladby, Tormod, Loercher, Amy E, Byrne, Gerard J, Murray, Frances, Scott-Stevens, Paul T, Wallin, Anders, Zhang, Yinghua Y, Bronge, Lena H, Zetterberg, Henrik, Nordberg, Agneta K, Yeo, Astrid J, Khan, Shahid A, Hilpert, Jan, Mistry, Prafull C
Published in PloS one (2015)
Published in PloS one (2015)
Get full text
Journal Article
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
Teng, Edmond, Manser, Paul T, Pickthorn, Karen, Brunstein, Flavia, Blendstrup, Mira, Sanabria Bohorquez, Sandra, Wildsmith, Kristin R, Toth, Bali, Dolton, Michael, Ramakrishnan, Vidya, Bobbala, Ashwini, Sikkes, Sietske A M, Ward, Michael, Fuji, Reina N, Kerchner, Geoffrey A
Published in Archives of neurology (Chicago) (01.08.2022)
Published in Archives of neurology (Chicago) (01.08.2022)
Get full text
Journal Article
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
Landen, Jaren W, Andreasen, Niels, Cronenberger, Carol L, Schwartz, Pamela F, Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine A, Binneman, Brendon, Bednar, Martin M
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2017)
Published in Alzheimer's & dementia : translational research & clinical interventions (01.09.2017)
Get full text
Journal Article
Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of Ponezumab (PF-04360365) in subjects with mild-to-moderate Alzheimer's disease
Landen, Jaren, Andreasen, Niels, Cronenberger, Carol, Schwartz, Pam, Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine, Kupiec, James, Binneman, Brendon, Bednar, Martin
Published in Alzheimer's & dementia (01.07.2012)
Published in Alzheimer's & dementia (01.07.2012)
Get full text
Journal Article
P4‐209: Safety, tolerability, pharmacokinetics and pharmacodynamics of monthly and quarterly doses of Ponezumab (PF‐04360365) in subjects with mild‐to‐moderate Alzheimer's disease
Landen, Jaren, Andreasen, Niels, Cronenberger, Carol, Schwartz, Pam, Börjesson‐Hanson, Anne, Östlund, Henrik, Sattler, Catherine, Kupiec, James, Binneman, Brendon, Bednar, Martin
Published in Alzheimer's & dementia (01.07.2012)
Published in Alzheimer's & dementia (01.07.2012)
Get full text
Journal Article
First Administration of the Fc-Attenuated Anti-[beta] Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study
Andreasen, Niels, Simeoni, Monica, Ostlund, Henrik, Lisjo, Pia I, Fladby, Tormod, Loercher, Amy E, Byrne, Gerard J, Murray, Frances, Scott-Stevens, Paul T, Wallin, Anders, Zhang, Yinghua Y, Bronge, Lena H, Zetterberg, Henrik, Nordberg, Agneta K, Yeo, Astrid J, Khan, Shahid A, Hilpert, Jan, Mistry, Prafull C
Published in PloS one (19.03.2015)
Published in PloS one (19.03.2015)
Get full text
Journal Article
First Administration of the Fc-Attenuated Anti- beta Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study: e0098153
Andreasen, Niels, Simeoni, Monica, Ostlund, Henrik, Lisjo, Pia I, Fladby, Tormod, Loercher, Amy E, Byrne, Gerard J, Murray, Frances, Scott-Stevens, Paul T, Wallin, Anders
Published in PloS one (01.03.2015)
Published in PloS one (01.03.2015)
Get full text
Journal Article